David Dietz, University at Buffalo (IMAGE) University at Buffalo Caption Dietz is principal investigator on the $2 million NIDA grant, which has the potential to identify novel therapies for treating cocaine addiction. Credit Douglas Levere, University at Buffalo Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.